Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of con...
Saved in:
| Published in | Journal of multidisciplinary healthcare Vol. 14; pp. 1711 - 1724 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Dove Medical Press Limited
01.01.2021
Taylor & Francis Ltd Dove Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices - today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted. |
|---|---|
| AbstractList | Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices--today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted. Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices--today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted. Keywords: targeting, polymers, nanoparticles, carriers, nanosomes Ashagrachew Tewabe,1 Atlaw Abate,2 Manaye Tamrie,3 Abyou Seyfu,3 Ebrahim Abdela Siraj1 1Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; 2Ethiopian Food and Drug Authority (EFDA), Federal Ministry of Health (FMoH), Addis Ababa, Ethiopia; 3Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Mizan-Tepi University, Mizan-Aman, EthiopiaCorrespondence: Ashagrachew TewabeDepartment of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, PO Box 79, Bahir Dar, EthiopiaTel +251 91-296-0525Email ashutewabe@gmail.comAbstract: Nanomedicine is an advanced version of Paul Ehrlich’s “magic bullet” concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices — today’s nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted.Keywords: targeting, polymers, nanoparticles, carriers, nanosomes Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices - today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted.Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices - today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted. |
| Audience | Academic |
| Author | Tewabe, Ashagrachew Abate, Atlaw Seyfu, Abyou Abdela Siraj, Ebrahim Tamrie, Manaye |
| Author_xml | – sequence: 1 givenname: Ashagrachew orcidid: 0000-0001-5122-7684 surname: Tewabe fullname: Tewabe, Ashagrachew – sequence: 2 givenname: Atlaw orcidid: 0000-0003-4326-7154 surname: Abate fullname: Abate, Atlaw – sequence: 3 givenname: Manaye orcidid: 0000-0002-8632-748X surname: Tamrie fullname: Tamrie, Manaye – sequence: 4 givenname: Abyou orcidid: 0000-0002-1598-8395 surname: Seyfu fullname: Seyfu, Abyou – sequence: 5 givenname: Ebrahim orcidid: 0000-0003-4921-6526 surname: Abdela Siraj fullname: Abdela Siraj, Ebrahim |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34267523$$D View this record in MEDLINE/PubMed |
| BookMark | eNptks9u1DAQxiNURP_AjTOKhIQ4dJfYTmyHA1LZZWlRC5UoZ8txJllXjr3YSaXeeAiekCfB6S5lt6p88Gj8m288o-8w2bPOQpK8RNkUo5y9-3IxP51-J4iUlD9JDhBifIJJme1txfvJYQjXWUY55uxZsk9yTFmByUHSXUnfQg91OvdDm87B6Bvwt-mfX7_ThXddeiFbrdKPgzHQp71Lv0rrOqi10hbep5deW6VXBsJxOlvKCNl2jKWt08XQDx7SS_BhBaqPuuF58rSRJsCLzX2U_Fh8upqdTs6_fT6bnZxPVMFoP6FFxUnFakSg5LjMIMtZw2ktSSMhRw0tVA05bQhhktMMU1CENxVmSEGpspocJWdr3drJa7HyupP-VjipxV3C-VZI32tlQFSxA1QYCkA8VwiVDUFY1YhJKHKkSNT6sNZaDVUcXIHtvTQ7orsvVi9F624Ex6zI-SjwdiPg3c8BQi86HRQYIy24IQhcFLhknJZZRF8_QK_d4G1c1R1FSkIZ_0-1Mg6gbeNiXzWKihPKMM0ZLcpITR-h4qmh0yp6qNExv1PwZqtgCdL0y-DM0Gtnwy74ansj96v456oIHK8B5V0IHpp7BGViNK0YTSs2po04foAr3cuxbfyxNo8X_QXCGO2r |
| CitedBy_id | crossref_primary_10_1039_D3NH00491K crossref_primary_10_51847_8GXFWD0Svq crossref_primary_10_1016_j_medntd_2024_100325 crossref_primary_10_3390_app12168262 crossref_primary_10_1016_j_jmmm_2023_171053 crossref_primary_10_1088_2053_1591_ac60e1 crossref_primary_10_1021_acsbiomedchemau_4c00092 crossref_primary_10_1016_j_ccr_2022_214977 crossref_primary_10_1021_acs_chemrev_4c00595 crossref_primary_10_1080_10837450_2024_2320279 crossref_primary_10_1186_s40001_022_00833_6 crossref_primary_10_3390_ma18030570 crossref_primary_10_1016_j_jconrel_2023_06_034 crossref_primary_10_1002_smsc_202400192 crossref_primary_10_1016_j_ipha_2025_01_001 crossref_primary_10_3390_ma17133070 crossref_primary_10_1002_smtd_202301068 crossref_primary_10_2174_0122117385280541231130055458 crossref_primary_10_1039_D3QM00139C crossref_primary_10_1186_s11671_024_04002_y crossref_primary_10_3390_biomedicines11071907 crossref_primary_10_1039_D4AY00821A crossref_primary_10_1021_acsptsci_3c00330 crossref_primary_10_2174_1570180820666230222092950 crossref_primary_10_3390_pharmaceutics15020471 crossref_primary_10_1002_adfm_202402975 crossref_primary_10_1016_j_jddst_2023_104781 crossref_primary_10_1016_j_saa_2023_123038 crossref_primary_10_1039_D4NR03493G crossref_primary_10_1016_j_jsps_2024_102085 crossref_primary_10_1002_slct_202403409 crossref_primary_10_1007_s00210_024_03256_8 crossref_primary_10_1021_acs_langmuir_4c01532 crossref_primary_10_1080_00914037_2022_2132248 crossref_primary_10_3390_pharmaceutics16060802 crossref_primary_10_1016_j_jddst_2023_104945 crossref_primary_10_1002_mnfr_202200192 crossref_primary_10_1007_s13346_024_01655_1 crossref_primary_10_1208_s12249_023_02504_z crossref_primary_10_1007_s13346_024_01708_5 crossref_primary_10_2174_1566524023666230818142831 crossref_primary_10_1007_s12668_024_01778_2 crossref_primary_10_1021_acsami_4c16261 crossref_primary_10_1186_s12934_024_02609_5 crossref_primary_10_1007_s10973_024_13225_1 crossref_primary_10_1134_S0022093023020175 crossref_primary_10_1007_s42247_023_00620_x crossref_primary_10_1016_j_envres_2023_117007 crossref_primary_10_1007_s00405_022_07374_y crossref_primary_10_1016_j_molliq_2024_126767 crossref_primary_10_3390_polym14142900 crossref_primary_10_1002_adbi_202200308 crossref_primary_10_1002_admt_202301044 crossref_primary_10_1016_j_engmic_2022_100034 crossref_primary_10_1016_j_lfs_2022_120922 crossref_primary_10_1021_acsomega_3c04187 crossref_primary_10_1002_adhm_202400833 crossref_primary_10_1016_j_rechem_2025_102115 crossref_primary_10_1039_D3TB03004K crossref_primary_10_1080_08982104_2023_2274428 crossref_primary_10_1002_adtp_202400189 crossref_primary_10_1016_j_colsurfb_2024_114478 crossref_primary_10_1002_jbm_a_37803 crossref_primary_10_1002_adma_202310872 crossref_primary_10_1080_10717544_2022_2069881 crossref_primary_10_3390_scipharm91020027 crossref_primary_10_1016_j_ijpharm_2023_123277 crossref_primary_10_1039_D4RA01634C crossref_primary_10_1080_10717544_2023_2232952 crossref_primary_10_3390_nano12244494 crossref_primary_10_3390_pharmaceutics16020273 crossref_primary_10_1016_j_jddst_2024_105506 crossref_primary_10_3390_ijms242216470 crossref_primary_10_1007_s13404_023_00331_5 crossref_primary_10_1016_j_jddst_2024_105985 crossref_primary_10_3390_ma17020456 crossref_primary_10_2174_0113816128321468240828103439 crossref_primary_10_1016_j_molliq_2023_123888 crossref_primary_10_1016_j_prmcm_2024_100559 crossref_primary_10_1016_j_ntm_2024_100054 crossref_primary_10_3390_polym14163271 crossref_primary_10_1002_cben_202300051 crossref_primary_10_1016_j_jconrel_2025_02_058 crossref_primary_10_1016_j_molliq_2024_125968 crossref_primary_10_1007_s00210_024_03234_0 crossref_primary_10_1016_j_molliq_2024_124639 crossref_primary_10_1111_dom_15759 crossref_primary_10_18502_wkmj_v66i2_16452 crossref_primary_10_1016_j_nwnano_2023_100025 crossref_primary_10_3390_cimb45120624 crossref_primary_10_1007_s41403_024_00484_5 crossref_primary_10_1080_09205063_2023_2279792 crossref_primary_10_1016_j_jddst_2023_104408 crossref_primary_10_2147_IJN_S457302 crossref_primary_10_3389_fnins_2023_1137096 crossref_primary_10_1002_smll_202410440 crossref_primary_10_1016_j_mseb_2023_116816 crossref_primary_10_1039_D3BM00813D crossref_primary_10_1016_j_bioadv_2024_213839 crossref_primary_10_1016_j_onano_2023_100178 crossref_primary_10_22159_ijap_2023v15i2_46970 crossref_primary_10_3390_pharmaceutics16050626 crossref_primary_10_1124_jpet_123_001690 crossref_primary_10_3390_pharmaceutics14020350 crossref_primary_10_1007_s00432_023_05331_8 crossref_primary_10_1016_j_ijpharm_2025_125486 crossref_primary_10_1155_2023_8902963 crossref_primary_10_1557_s43578_023_01120_8 crossref_primary_10_1186_s12951_025_03298_x crossref_primary_10_1208_s12249_023_02670_0 crossref_primary_10_1016_j_ijbiomac_2025_140748 crossref_primary_10_1016_j_reactfunctpolym_2024_105830 crossref_primary_10_1039_D4RA02439G crossref_primary_10_1007_s12247_024_09808_y crossref_primary_10_1016_j_jgeb_2024_100400 crossref_primary_10_54097_hset_v6i_957 crossref_primary_10_1039_D3TB02268D crossref_primary_10_1016_j_matdes_2023_112064 crossref_primary_10_3390_jfb15080209 crossref_primary_10_1088_1748_605X_ad1dfb crossref_primary_10_1208_s12249_024_02847_1 crossref_primary_10_1002_mabi_202300590 crossref_primary_10_1007_s11696_024_03463_w crossref_primary_10_1016_j_jddst_2024_105571 crossref_primary_10_1177_10732748241274978 crossref_primary_10_3389_fimmu_2024_1437430 crossref_primary_10_3390_pharmaceutics16040533 crossref_primary_10_1038_s41417_022_00427_8 crossref_primary_10_2174_0115734129344438240927100440 crossref_primary_10_3390_ijms24043493 crossref_primary_10_1016_j_rechem_2024_101769 crossref_primary_10_2174_0122103031304556240430161553 crossref_primary_10_3390_pharmaceutics15010236 crossref_primary_10_1016_j_ijpharm_2022_122254 crossref_primary_10_1016_j_nano_2022_102613 crossref_primary_10_1080_17425247_2025_2484309 crossref_primary_10_1016_j_addr_2024_115386 crossref_primary_10_1016_j_jddst_2023_105039 crossref_primary_10_1007_s00210_024_03466_0 crossref_primary_10_1016_j_ijbiomac_2023_127670 crossref_primary_10_1016_j_biopha_2024_117183 crossref_primary_10_3390_polym15194034 crossref_primary_10_1002_cbdv_202301157 crossref_primary_10_1039_D1RA04835J crossref_primary_10_3390_ijms25094981 crossref_primary_10_1016_j_jtice_2025_105992 crossref_primary_10_3390_ijms241914649 crossref_primary_10_31857_S0869813923030093 crossref_primary_10_1002_advs_202407850 crossref_primary_10_3390_pharmaceutics14122712 crossref_primary_10_3389_fbioe_2024_1511149 crossref_primary_10_1016_j_ijpharm_2022_122065 crossref_primary_10_1016_j_ijpx_2022_100136 crossref_primary_10_1080_00914037_2022_2155158 crossref_primary_10_47162_RJME_65_2_01 crossref_primary_10_1080_03007995_2024_2416985 crossref_primary_10_1186_s12951_023_02159_9 crossref_primary_10_1016_j_ijpharm_2024_124441 crossref_primary_10_1016_j_addr_2023_114840 crossref_primary_10_3390_pharmaceutics13122147 crossref_primary_10_1016_j_ejmech_2024_116699 crossref_primary_10_1016_j_lfs_2024_122671 crossref_primary_10_1002_pol_20230579 crossref_primary_10_1007_s11144_022_02209_7 crossref_primary_10_62810_jnsr_v2i4_106 crossref_primary_10_3390_ijms25020786 crossref_primary_10_1016_j_cis_2024_103163 crossref_primary_10_1080_00914037_2023_2222334 crossref_primary_10_29328_journal_cjog_1001162 crossref_primary_10_1007_s12013_024_01626_w crossref_primary_10_3390_biomedicines11041201 crossref_primary_10_1007_s41061_025_00497_w crossref_primary_10_3390_pharmaceutics15102491 crossref_primary_10_1016_j_chphma_2022_07_002 crossref_primary_10_1016_j_ijbiomac_2024_133472 crossref_primary_10_1080_17425247_2022_2047020 crossref_primary_10_1089_adt_2023_066 crossref_primary_10_3390_ma15207279 crossref_primary_10_1515_znc_2024_0043 crossref_primary_10_1021_acs_molpharmaceut_4c00589 crossref_primary_10_3390_pharmaceutics15102414 crossref_primary_10_2174_138955752203220202164839 crossref_primary_10_1016_j_comptc_2024_114634 |
| Cites_doi | 10.4103/0973-8398.107558 10.1038/s41578-020-00269-6 10.4236/jbnb.2011.225062 10.1038/s41563-019-0566-2 10.4103/0250-474X.25707 10.1016/j.jddst.2020.102079 10.1016/S0928-0987(01)00147-6 10.1016/j.jconrel.2011.06.001 10.2174/157341309787314566 10.1166/jnn.2006.413 10.1080/15685551.2019.1591681 10.1016/j.ijpharm.2006.12.005 10.1016/j.jconrel.2012.07.010 10.1016/j.jconrel.2011.09.098 10.1007/s40089-014-0094-7 10.1038/s41573-020-0090-8 10.1016/0031-6865(95)00010-7 10.4155/tde.14.63 10.2217/nnm.15.146 10.3390/cancers11050640 10.1038/s41467-018-03705-y 10.4321/S0211-95362011000200003 10.1080/10717544.2020.1831106 10.1159/000443526 10.1080/1061186X.2017.1401076 10.1016/S1369-7021(05)71033-6 10.1517/17425247.5.4.459 10.1517/13543776.9.11.1499 |
| ContentType | Journal Article |
| Copyright | 2021 Tewabe et al. COPYRIGHT 2021 Dove Medical Press Limited 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Tewabe et al. 2021 Tewabe et al. |
| Copyright_xml | – notice: 2021 Tewabe et al. – notice: COPYRIGHT 2021 Dove Medical Press Limited – notice: 2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Tewabe et al. 2021 Tewabe et al. |
| DBID | AAYXX CITATION NPM 3V. 7RV 7XB 8C1 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH KB0 M2O MBDVC NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.2147/JMDH.S313968 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library Nursing & Allied Health Database (Alumni Edition) ProQuest Research Library Research Library (Corporate) ProQuest Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Sustainability Health Research Premium Collection ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| DocumentTitleAlternate | Tewabe et al |
| EISSN | 1178-2390 |
| EndPage | 1724 |
| ExternalDocumentID | oai_doaj_org_article_b982eb2e5e184c119f312cd17ae541c3 PMC8275483 A672647659 34267523 10_2147_JMDH_S313968 |
| Genre | Journal Article Review |
| GeographicLocations | Ethiopia |
| GeographicLocations_xml | – name: Ethiopia |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- 0YH 29L 2WC 5GY 5VS 7RV 8C1 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ADBBV ADRAZ AEUYN AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ CCPQU CITATION DIK DWQXO EBD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M2O M48 MK0 M~E NAPCQ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RNS RPM TDBHL UKHRP VDV NPM PJZUB PPXIY PMFND 3V. 7XB 8FK MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c576t-65b83b7d13e98290e047f86da3fae41f65cde46f337a86026ec38fb271ce9c0d3 |
| IEDL.DBID | M48 |
| ISSN | 1178-2390 |
| IngestDate | Wed Aug 27 01:29:11 EDT 2025 Thu Aug 21 18:22:09 EDT 2025 Mon Jul 21 11:08:02 EDT 2025 Sat Jul 26 03:28:05 EDT 2025 Tue Jun 17 21:23:34 EDT 2025 Tue Jun 10 20:28:54 EDT 2025 Thu May 22 21:24:03 EDT 2025 Mon Jul 21 06:04:39 EDT 2025 Tue Jul 01 04:26:06 EDT 2025 Thu Apr 24 23:10:33 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | nanosomes targeting carriers nanoparticles polymers |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 2021 Tewabe et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c576t-65b83b7d13e98290e047f86da3fae41f65cde46f337a86026ec38fb271ce9c0d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-1598-8395 0000-0001-5122-7684 0000-0002-8632-748X 0000-0003-4326-7154 0000-0003-4921-6526 |
| OpenAccessLink | https://doaj.org/article/b982eb2e5e184c119f312cd17ae541c3 |
| PMID | 34267523 |
| PQID | 2552393678 |
| PQPubID | 3933407 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b982eb2e5e184c119f312cd17ae541c3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8275483 proquest_miscellaneous_2552978690 proquest_journals_2552393678 gale_infotracmisc_A672647659 gale_infotracacademiconefile_A672647659 gale_healthsolutions_A672647659 pubmed_primary_34267523 crossref_primary_10_2147_JMDH_S313968 crossref_citationtrail_10_2147_JMDH_S313968 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
| PublicationTitle | Journal of multidisciplinary healthcare |
| PublicationTitleAlternate | J Multidiscip Healthc |
| PublicationYear | 2021 |
| Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
| Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
| References | Barz (ref13) 2015; 10 Laouini (ref39) 2012 Bhargav (ref20) 2013; 3 Mahajan (ref17) 2007; 39 Elsayed (ref43) 2007 Mirza (ref56) 2014; 4 Haijiao (ref48) 2016 Yoo (ref6) 2019; 11 Rani (ref15) 2014; 2 (ref26) 2015 Scott (ref29) 2008; 5 Akhtar (ref4) 2020; 60 Rosenblum (ref54) 2018; 9 Manish (ref19) 2011; 1 Muro (ref59) 2012; 3 Martinho (ref52) 2011; 2 Thakur (ref2) 2015 Ali (ref7) 2015; 22 (ref18) 2004 Gradmann (ref12) 2011; 31 He (ref24) 2020; 27 Biju (ref33) 2006; 68 Kıvılcım (ref28) 2017 Xiaojiao (ref30) 2016 Benyettou (ref10) 2016; 8 Bae (ref14) 2011; 153 Fahmy (ref9) 2005; 8 Jin (ref22) 2020 Abu-Dahab (ref38) 2001; 14 Idayu (ref31) 2015 Vhora (ref53) 2014; 5 Shukla (ref42) 2016; 6 Mitchell (ref58) 2021; 20 Zishan (ref1) 2017; 5 Freitas (ref55) 2006; 6 Priya (ref36) 2020; 12 Anwekar (ref37) 2011; 2 Vemuri (ref40) 1995; 70 Mills (ref25) 1999; 9 (ref50) 2006 Stevanovi (ref47) 2009; 5 Bertrand (ref27) 2012; 161 Kwon (ref5) 2012; 164 Gattani (ref45) 2010; 6 Gujral (ref16) 2013; 2 Erkoc (ref21) 2015 Arora (ref35) 2012; 6 Kumar (ref3) 2017; 5 Manzari (ref57) 2021; 6 Sunil (ref34) 2013 Jain (ref41) 2001 Rav (ref51) 2019; 4 Bhardwaj (ref32) 2011; 1 Yousaf (ref49) 2019; 22 Sindhwani (ref23) 2020; 19 Seema (ref44) 2012; 2 Valent (ref11) 2016; 8 Ravinder (ref46) 2014; 4 Mishra (ref8) 2016; 6 |
| References_xml | – start-page: 288 year: 2015 ident: ref31 publication-title: Nanomedicine – year: 2015 ident: ref2 publication-title: SMGroup – volume: 6 year: 2016 ident: ref8 publication-title: Am J PharmTech Res – volume: 6 start-page: 237 year: 2012 ident: ref35 publication-title: Asian J Pharm doi: 10.4103/0973-8398.107558 – volume: 6 start-page: 351 year: 2021 ident: ref57 publication-title: Nat Rev Mater doi: 10.1038/s41578-020-00269-6 – volume: 4 start-page: 32 year: 2014 ident: ref46 publication-title: J Drug Deliv Ther – volume: 3 start-page: 1 year: 2012 ident: ref59 publication-title: J Nanomedic Nanotechnol – volume: 12 start-page: 7 year: 2020 ident: ref36 publication-title: Int J App Pharm – volume: 2 start-page: 510 year: 2011 ident: ref52 publication-title: J Biomater Nanobiotechnol doi: 10.4236/jbnb.2011.225062 – volume-title: Targeted & Controlled Drug Delivery: Novel Carrier Systems year: 2004 ident: ref18 – volume: 19 start-page: 566 year: 2020 ident: ref23 publication-title: Nat Mater doi: 10.1038/s41563-019-0566-2 – start-page: 14 year: 2020 ident: ref22 publication-title: J Nanomater – volume: 1 start-page: 102 year: 2011 ident: ref32 publication-title: Am J PharmTech Res – volume: 68 start-page: 141 year: 2006 ident: ref33 publication-title: Indian J Pharm Sci doi: 10.4103/0250-474X.25707 – volume: 60 start-page: 102079 year: 2020 ident: ref4 publication-title: J Drug Deliv Sci Technol doi: 10.1016/j.jddst.2020.102079 – volume: 14 start-page: 37 year: 2001 ident: ref38 publication-title: Eur J Pharm Sci doi: 10.1016/S0928-0987(01)00147-6 – volume: 4 start-page: 1 year: 2019 ident: ref51 publication-title: ARC J Public Health Commun Med – volume: 153 start-page: 198 year: 2011 ident: ref14 publication-title: J Control Release doi: 10.1016/j.jconrel.2011.06.001 – volume: 5 start-page: 1 year: 2009 ident: ref47 publication-title: Curr Nanosci doi: 10.2174/157341309787314566 – volume: 22 start-page: 1,91 year: 2015 ident: ref7 publication-title: Des Monomers Polym – volume: 6 start-page: 2769 year: 2006 ident: ref55 publication-title: J Nanosci Nanotechnol doi: 10.1166/jnn.2006.413 – start-page: 121 year: 2013 ident: ref34 publication-title: Int J Drug Deliv – volume: 39 year: 2007 ident: ref17 publication-title: Pharma Times – volume: 3 start-page: 150 year: 2013 ident: ref20 publication-title: World J Pharm Pharm Sci – volume: 22 start-page: 91 year: 2019 ident: ref49 publication-title: Des Monomers Polym doi: 10.1080/15685551.2019.1591681 – start-page: 1 year: 2007 ident: ref43 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2006.12.005 – volume: 164 start-page: 108 year: 2012 ident: ref5 publication-title: J Control Release doi: 10.1016/j.jconrel.2012.07.010 – volume: 161 start-page: 152 year: 2012 ident: ref27 publication-title: J Control Release doi: 10.1016/j.jconrel.2011.09.098 – volume: 4 start-page: 94 year: 2014 ident: ref56 publication-title: Int Nano Lett doi: 10.1007/s40089-014-0094-7 – volume: 1 start-page: 135 year: 2011 ident: ref19 publication-title: Res J Chem Sci – volume: 20 start-page: 101 year: 2021 ident: ref58 publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-020-0090-8 – volume: 70 start-page: 95 year: 1995 ident: ref40 publication-title: Pharm Acta Helv doi: 10.1016/0031-6865(95)00010-7 – volume: 2 start-page: 193 year: 2012 ident: ref44 publication-title: J Appl Pharm Sci – volume: 5 start-page: 1007 year: 2014 ident: ref53 publication-title: Ther Deliv doi: 10.4155/tde.14.63 – volume: 2 start-page: 328 year: 2014 ident: ref15 publication-title: Sch J App Med Sci – volume: 5 start-page: 448 year: 2017 ident: ref3 publication-title: Int J Pharm Med Res – volume-title: Targeted Drug Delivery: Concepts and Design year: 2015 ident: ref26 – volume: 10 start-page: 3093 year: 2015 ident: ref13 publication-title: Nanomedicine (Lond) doi: 10.2217/nnm.15.146 – volume: 11 start-page: 640 year: 2019 ident: ref6 publication-title: Cancers doi: 10.3390/cancers11050640 – volume: 2 start-page: 945 year: 2011 ident: ref37 publication-title: Int J Pharm Life Sci – volume: 9 start-page: 1410 year: 2018 ident: ref54 publication-title: Nat Commun doi: 10.1038/s41467-018-03705-y – volume: 31 start-page: 305 year: 2011 ident: ref12 publication-title: Dynamis doi: 10.4321/S0211-95362011000200003 – volume: 27 start-page: 1474 year: 2020 ident: ref24 publication-title: Drug Deliv doi: 10.1080/10717544.2020.1831106 – volume: 5 start-page: 28 year: 2017 ident: ref1 publication-title: World J Pharm Sci – start-page: 149 year: 2012 ident: ref39 publication-title: J Colloid Sci Biotechnol – volume: 6 start-page: 35 year: 2010 ident: ref45 publication-title: Int J Pharma Bio Sci – volume-title: NPs as Drug Carriers year: 2006 ident: ref50 – volume: 8 start-page: 111 year: 2016 ident: ref11 publication-title: J Innate Immun doi: 10.1159/000443526 – year: 2017 ident: ref28 publication-title: J Drug Target doi: 10.1080/1061186X.2017.1401076 – volume: 8 start-page: 18 year: 2005 ident: ref9 publication-title: Mater Today doi: 10.1016/S1369-7021(05)71033-6 – year: 2015 ident: ref21 publication-title: SMGroup – start-page: 2 year: 2001 ident: ref41 publication-title: J Colloid Sci Biotechnol – volume: 8 start-page: 2 year: 2016 ident: ref10 publication-title: J Bioanal Biomed – start-page: 2 year: 2016 ident: ref30 publication-title: J Nanomater – start-page: 2 year: 2016 ident: ref48 publication-title: J Nanomater – volume: 6 start-page: 40 year: 2016 ident: ref42 publication-title: Int J Pharm Pharm Sci – volume: 2 year: 2013 ident: ref16 publication-title: IJAPBC – volume: 5 start-page: 459 year: 2008 ident: ref29 publication-title: Expert Opin Drug Deliv doi: 10.1517/17425247.5.4.459 – volume: 9 start-page: 1499 year: 1999 ident: ref25 publication-title: Exp Opin Ther Patents doi: 10.1517/13543776.9.11.1499 |
| RelatedPersons | Ehrlich, Paul (German bacteriologist) |
| RelatedPersons_xml | – fullname: Ehrlich, Paul (German bacteriologist) |
| SSID | ssj0068287 |
| Score | 2.5987997 |
| SecondaryResourceType | review_article |
| Snippet | Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into... Nanomedicine is an advanced version of Paul Ehrlich’s “magic bullet” concept. Targeted drug delivery is a system of specifying the drug moiety directly into... Ashagrachew Tewabe,1 Atlaw Abate,2 Manaye Tamrie,3 Abyou Seyfu,3 Ebrahim Abdela Siraj1 1Department of Pharmacy, College of Medicine and Health Sciences, Bahir... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1711 |
| SubjectTerms | carriers Drug delivery systems Drug dosages Drug therapy Drugs Ehrlich, Paul (German bacteriologist) Enzymes Health aspects nanoparticles nanosomes Pharmaceuticals Pharmacokinetics Physiology Polymers Principles Review targeting Toxicity Tumors Vehicles |
| SummonAdditionalLinks | – databaseName: DOAJ Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT5UQgvIKlGIkEAcIjePETnorXVarSosq0Uq9WY4fgCgJ2seBf8-MnYSNEOLCbRVPVolnPDOfM_6GkJe2gJirWZPmwpu0KDKbNjmzaeWtrZFBnQUqpeVHsbgqzq_L651WX1gTFumB48QdN3WVA_pzpQMsYhirPWe5sUxqVxbMBJ5PiHkDmIo-WCCNe2yrAnYAsD6WvGNPnuPz5Wzx7hOHzAfpVXeCUeDs_9Mz74SmadnkThya3yV3-gSSnsYHv0duufaA3I67bzQeKrpPvl2GAm9n6Wy1_Uxn7gbLL37SlM5X3Xe61ODvaGTeppuOgovtho_sJ_Ri2H9fv6VnQ68V-K1bS-eBgoRe_D6iuX5AruYfLs8Wad9WITUALjapKJuKN9Iy7mr8jOqyQvpKWM29dgXzojTWFcJzLnXoUOUMr3yTS2ZcbTLLH5K9tmvdY0Kt8x7u1bawAMyaRuuqzJiurBO5EZVIyJthfpXpOcex9cWNAuyB2lCoDdVrIyGvRukfkWvjL3LvUVWjDDJkhwtgN6q3G_Uvu0nIc1S0isdNx3WuToWEHFGKsk7I6yCBKx0e2uj-wAK8OnJmTSQPJ5KwQs10eDAm1XuItQIoh-xzkCsk5MU4jHdi1Vvrum2UAZQv6iwhj6LtjS_NIbWS8BcJkROrnMzKdKT9-iXwh1e5BJzKn_yPaXxK9nOs8gmbUodkb7PaumeQpm2ao7AifwGxAzi4 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvSAhxJtAASOBOEBoHCd2wgW13a5WlbZaQSv1ZvmVgtQmZR8HbvwIfiG_hJnE2W6E4BbF4yj2eMYz4_E3hLx2Gey5mpk4FZWNsyxxsUmZi4vKuRIR1FkLpTQ9FpPT7OgsPwsBt0VIq-x1YquoXWMxRr4Lpi-idYFu_XT1PcaqUXi6Gkpo3CTboIILcL629w-PZ597XSwQzr1Ld8d6PLtH09HkwxcOVg9Cq25sRC1e_99aeWNbGqZMbuxB47vkTjAe6V7H7Xvkhq_vk9td5I12F4oekMuTNrnbOzqar87pyF9g6sUP-vvnLzqeN5d0qkHb0Q53my4bCgq26Y_YP9JZH31fvKcHfaUVeNa1o-MWgITOri9oLh6S0_HhycEkDkUVYguuxTIWuSm4kY5xX-Ihqk8yWRXCaV5pn7FK5Nb5TFScS93Wp_KWF5VJJbO-tInjj8hW3dT-CaHOVxX01S5z4JYZo3WRJ0wXzovUikJE5F0_w8oGxHEsfHGhwPNAfijkhwr8iMibNfVVh7TxD7p9ZNaaBvGx2xfN_FwFcVMGxuZN6nMPHqxlrKw4S61jUvs8Y5ZH5CWyWnWXTddSrvaEBAtRiryMyNuWAuUcftrqcF0Bho6IWQPKnQElyKcdNvfLSQX9sFDXqzkir9bN2BNz3mrfrDoa8PFFmUTkcbf61oPmYFhJ-ERE5GBdDmZl2FJ_-9qihxepBC-VP_3_bz0jt1LM3mmDTTtkazlf-edgfi3NiyBjfwCj_zGX priority: 102 providerName: ProQuest |
| Title | Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34267523 https://www.proquest.com/docview/2552393678 https://www.proquest.com/docview/2552978690 https://pubmed.ncbi.nlm.nih.gov/PMC8275483 https://doaj.org/article/b982eb2e5e184c119f312cd17ae541c3 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwED_t8QUJId4ERjESiA-QEceOnSAhtLWrqkmdKlil8SlybGdMKwn0IbH_nnNeLBpIfKmi-pzWvjvfnX3-HcArw9HmKpr5oci1z3lg_Cykxo9zYxKHoE4rKKXpiZjM-fFZdLYFbbXRZgJXfw3tXD2p-XKx_-vn1SdU-I8ujZly-f54Oprsf2Hoy4h4G3bRJkmnolPenScIB-tel1lBucAwv06Bv9G7Z5wqDP-bK_U1U9VPo7xml8Z34U7jUJKDWgLuwZYt7sPtejeO1JeMHsDlaZXwbQ0ZLTfnZGQXLh3jivhkvCy_k6nC9Y_USNxkXRJccsv20P0DmbX78at3ZNjWXsFnVRgyriBJyOzPlc3VQ5iPj06HE78ps-BrDDbWvoiymGXSUGYTd6xqAy7zWBjFcmU5zUWkjeUiZ0yqqmKV1SzOs1BSbRMdGPYIdoqysE-AGJvn2FcZbjBQyzKl4iigKjZWhFrEwoO37fymusEgd6UwFinGIo4bqeNG2nDDg9cd9Y8ae-MfdIeOVR2NQ8yuviiX52mjgGmGY7NZaCOLMa2mNMkZDbWhUtmIU808eOEYndbXTzu9Tw-ERJ9Riijx4E1F4WQR_7RWzQUGHLrD0OpR7vUoUWN1v7kVprQV-BRDO4dGh76DBy-7ZtfTZcEVttzUNBj1iyTw4HEte92gGbpaEl_hgexJZW9W-i3FxbcKTzwOJcat7Ol__O4zuBW6pJ5qD2oPdtbLjX2OXtk6G8B28HWCn_GQDmD38Ohk9nlQ7XAMKlX8DVeBONM |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AASQrwxFLpIVBzAbdZrrx0khNqmUfpIFEEq9WbWu-uC1NolD6He-BH8Dn4Uv4QZP9JYCG69Rdmx5d2ZncfuzDcAr4yPNlfxxPVkql3fbxs38bhxo9SYDiGo8wJKaTCU_WP_4CQ4WYFfdS0MpVXWOrFQ1CbXdEa-ha4voXWhbv1w8c2lrlF0u1q30CjF4tBefseQbfp-v4v83fC83t54t-9WXQVcjb71zJVBEokkNFzYDt0i2rYfppE0SqTK-jyVgTbWl6kQoSoaNFktojTxQq5tR7eNwPfegFVfYCjTgtWdveHoY637JcHHl-n11P9n62DQ7W9-EuhlEZTrkuEr-gP8bQWWzGAzRXPJ5vXuwp3KWWXbpXTdgxWb3Yfb5UkfKwuYHsD5uEgmt4Z1J_NT1rVnlOpxyX7_-Ml6k_ycDRRqV1bifLNZzlCh5_WV_js2qk_7p2_Zbt3ZBX-rzLBeAXjCRlcFodOHcHwty_0IWlme2SfAjE1TfFYZ32AYmCRKRUGbq8hY6WkZSQfe1Csc6wrhnBptnMUY6RA_YuJHXPHDgY0F9UWJ7PEPuh1i1oKG8LiLP_LJaVxt7zjBudnEs4HFiFlz3kkF97ThobKBz7VwYJ1YHZfFrQutEm_LED3SUAYdB14XFKRX8KO1qsojcOqE0NWgXGtQoj7QzeFanOJKH03jq93jwMvFMD1JOXaZzeclTSekDmUOPC6lbzFpgY5ciK9wIGzIZWNVmiPZ1y8FWnnkhRgVi6f__6x1uNkfD47io_3h4TO45VHmUHHQtQat2WRun6PrN0teVPuNwefr3uJ_AEkjbsY |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELVKkRASQtwJFGokKh4g7DpO7AQJobLLatuy1Uq0Ut-MYzsFqU3KXoT6xkfwNXwOX8JMbt0IwVvfVutJFHvGc7FnzhDy3IZgczVL_UBkxg_DvvXTgFk_zqxNEEGdlVBKk30xPgx3j6KjNfKrqYXBtMpGJ5aK2hYGz8h74PoiWhfo1l5Wp0VMh6N3Z9987CCFN61NO41KRPbc-XcI3-Zvd4bA660gGH04GIz9usOAb8DPXvgiSmOeSsu4S_BG0fVDmcXCap5pF7JMRMa6UGScS102a3KGx1kaSGZcYvqWw3uvkKuSg53FKvVBm14iEEi-SrTHTkC93clw_PoTB38LQV1XTGDZKeBve7BiELvJmivWb3SL3KzdVrpdydltsubyO-RGdeZHq1Kmu-T0oEwrd5YOZ8tjOnQnmPRxTn__-ElHs-KUTjToWVohftNFQUG1F83l_hs6bc7956_ooOnxAr91bumohD6h04vS0Pk9cngpi32frOdF7h4Sal2WwbPahhYCwjTVOo76TMfWicCIWHjkZbPCytRY59hy40RBzIP8UMgPVfPDI1st9VmF8fEPuvfIrJYGkbnLP4rZsao3ukphbi4NXOQgdjaMJRlngbFMaheFzHCPbCKrVVXm2uoXtS0k-KZSRIlHXpQUqGHgo42uCyVg6ojV1aHc6FCCZjDd4UacVK2Z5upiH3nkWTuMT2K2Xe6KZUWTSOxV5pEHlfS1k-bg0kl4hUdkRy47q9Idyb9-KXHL40BCfMwf_f-zNsk12Njq487-3mNyPcAUovLEa4OsL2ZL9wR8wEX6tNxslHy-7N39B8dScWo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeted+Drug+Delivery+-+From+Magic+Bullet+to+Nanomedicine%3A+Principles%2C+Challenges%2C+and+Future+Perspectives&rft.jtitle=Journal+of+multidisciplinary+healthcare&rft.au=Tewabe%2C+Ashagrachew&rft.au=Abate%2C+Atlaw&rft.au=Tamrie%2C+Manaye&rft.au=Seyfu%2C+Abyou&rft.date=2021-01-01&rft.issn=1178-2390&rft.eissn=1178-2390&rft.volume=14&rft.spage=1711&rft_id=info:doi/10.2147%2FJMDH.S313968&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-2390&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-2390&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-2390&client=summon |